HEMOGLOBIN A1C (HBA1C) AS A NOVEL BIOMARKER OF EMBRYO COMPETENCE AND PREGNANCY SUCCESS IN NON-DIABETIC SINGLE FROZEN EMBRYO TRANSFER (SFET) CYCLES

Objective: To evaluate whether pre-retrieval HbA1c predicts embryo competence and clinical pregnancy rate (CPR) in non-diabetic patients undergoing single frozen embryo transfer (sFET). Design: Retrospective cohort study Materials and Methods: 321 sFET cycles from non-diabetic women (HbA1c <6.5%) from January 2024 to December 2025 were included. Linear regression assessed HbA1c as a predictor of blastocyst count (BC), blastocyst-to-fertilized oocyte ratio (BFOR), and top- quality embryo (TQE) count defined as Gardner grade ≥2BB. Models were adjusted for age, body mass index (BMI), anti-mullerian hormone, ovulatory polycystic ovarian syndrome status and total gonadotropin dose. Logistic regression assessed CPR, adjusted for HbA1c, BMI and age. Significance was set at p<0.05. Results: Mean age was 35.4±4.1 years and mean BMI was 26.5±6.0. Mean HbA1c was 5.36±0.28% (range 4.2–6.3%), drawn a median of 4.0 months before retrieval. Among 280 complete cycles, each 0.7% rise in HbA1c was significantly associated with 1 fewer blastocyst (p=0.014). After adjustment for oocytes retrieved, this association was attenuated but directionally consistent (β = −0.931 per 1% HbA1c). HbA1c was associated with BFOR after adjustment for retrieved oocytes (p = 0.045), equivalent to 1 fewer blastocyst per 15 fertilized oocytes. Among 177 cycles with TQE data, each 0.5% rise in HbA1c was associated with 1 fewer TQE (β=−2.075, p<0.001; ΔR²=0.049). In 147 transfer cycles, CPR was 79.6% (117/147). Higher HbA1c was associated with lower pregnancy odds in exploratory analysis adjusted for age and BMI (OR=0.157 per 1% HbA1c, p=0.032). Conclusions: Subtle HbA1c elevations below the diabetic threshold were associated with fewer blastocysts, fewer TQE, lower embryo conversion efficiency and lower CPR. HbA1c may represent a readily available IVF biomarker warranting prospective study in non-diabetic patients.

Authors

Institutions

Publication Details

Journal
North American Proceedings in Gynecology and Obstetrics - Supplemental
Published
2026-07-25
DOI
https://doi.org/10.54053/001c.165492
Primary Topic
Ovarian function and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HEMOGLOBIN A1C (HBA1C) AS A NOVEL BIOMARKER OF EMBRYO COMPETENCE AND PREGNANCY SUCCESS IN NON-DIABETIC SINGLE FROZEN EMBRYO TRANSFER (SFET) CYCLES

Mehrnoosh Faghih, Mandakini Jain, Shilpa Amin, Naiya Amin et al.
North American Proceedings in Gynecology and Obstetrics - Supplemental
Ovarian function and disorders
article

HEMOGLOBIN A1C (HBA1C) AS A NOVEL BIOMARKER OF EMBRYO COMPETENCE AND PREGNANCY SUCCESS IN NON-DIABETIC SINGLE FROZEN EMBRYO TRANSFER (SFET) CYCLES

Mehrnoosh Faghih, Mandakini Jain, Shilpa Amin, Naiya Amin, Michael Neal, Meghan Karnis
article en

Abstract

Objective: To evaluate whether pre-retrieval HbA1c predicts embryo competence and clinical pregnancy rate (CPR) in non-diabetic patients undergoing single frozen embryo transfer (sFET). Design: Retrospective cohort study Materials and Methods: 321 sFET cycles from non-diabetic women (HbA1c <6.5%) from January 2024 to December 2025 were included. Linear regression assessed HbA1c as a predictor of blastocyst count (BC), blastocyst-to-fertilized oocyte ratio (BFOR), and top- quality embryo (TQE) count defined as Gardner grade ≥2BB. Models were adjusted for age, body mass index (BMI), anti-mullerian hormone, ovulatory polycystic ovarian syndrome status and total gonadotropin dose. Logistic regression assessed CPR, adjusted for HbA1c, BMI and age. Significance was set at p<0.05. Results: Mean age was 35.4±4.1 years and mean BMI was 26.5±6.0. Mean HbA1c was 5.36±0.28% (range 4.2–6.3%), drawn a median of 4.0 months before retrieval. Among 280 complete cycles, each 0.7% rise in HbA1c was significantly associated with 1 fewer blastocyst (p=0.014). After adjustment for oocytes retrieved, this association was attenuated but directionally consistent (β = −0.931 per 1% HbA1c). HbA1c was associated with BFOR after adjustment for retrieved oocytes (p = 0.045), equivalent to 1 fewer blastocyst per 15 fertilized oocytes. Among 177 cycles with TQE data, each 0.5% rise in HbA1c was associated with 1 fewer TQE (β=−2.075, p<0.001; ΔR²=0.049). In 147 transfer cycles, CPR was 79.6% (117/147). Higher HbA1c was associated with lower pregnancy odds in exploratory analysis adjusted for age and BMI (OR=0.157 per 1% HbA1c, p=0.032). Conclusions: Subtle HbA1c elevations below the diabetic threshold were associated with fewer blastocysts, fewer TQE, lower embryo conversion efficiency and lower CPR. HbA1c may represent a readily available IVF biomarker warranting prospective study in non-diabetic patients.

North American Proceedings in Gynecology and Obstetrics - SupplementalVol. Suppl(MRSi)
Western University (CA), Fertility Medical Group (BR), McMaster University (CA)
Good health and well-being
Openalex Percentile: Top 7%
Ovarian function and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.